R&D Projects / Neuro Device VOIC ™

Neuro Device VOIC ™

The idea of the project is development of the first in the world system for effective rehabilitation of speech disorders (aphasia). According to available data, as many as 1 in 250 persons in the world need such therapy. It will be possible to use the device not only during professional therapy, but also as a part of home therapy. It will guarantee acceleration of rehabilitation as well as significant improvement of its effects, giving patients the possibility to return to normal life.

About the problem

Aphasia means loosing abilities to communicate. Affected patient is forced to withdraw from family, social and professional life.

Aphasia’s cause despicable isolation. Unable to communicate, but with the intellect intact, patient is locked alone with his thoughts. Research say, that it has worst impact on life’s quality than symptoms of e.g. oncological or Alzheimer’s diseases.

Inability to communicate makes it impossible to come back to work  or take part in a  normal family life. It excludes young, otherwise able people from society and professional life. This creates huge costs for public health care system and social welfare.

There is no other solutions for this problem, which we could call satisfying. Standard therapy is a 45-minute session with a speech therapist, which in term of time is a drop in the ocean of needs. All over the world health care systems suffers from lack of therapists. But even if you are lucky enough to afford a private therapy it still is slow, not very affective, or not effective at all.

Solution & Technology

The device we designed changes quality of therapy, enhancing and accelerating it results. It also makes great change in terms of its accessibility and affordability, significantly reduces costs of therapy. Designed for easy use enables both professional and home application. 

Our device works on the principle of neuromodulation and electrical stimulation of the brain. The patient independently performs the exercises while working with special software, while the device affects the activity of neurons in the stimulated part of the brain. Thanks to this, sick areas regenerate faster and the patient recovers more quickly. Our device not only increases effectiveness of rehabilitation. It can be used both in institutions and at home, so the therapy becomes and much more available and cheaper.

  1. Option 1 – by a therapist in a neurorehabilitation center

    The patient signs up for therapy and gets connected to a stimulator. The therapist, depending on the patient’s condition, programs the stimulator. When the stimulation session is over, the patient proceeds to speech therapy.

  2. Option 2 – by the patient

    The device is adapted for individual use, settings are programmed in advance by the therapist, there is no need for adjustment. The device requires only putting it on one’s head and turning it on. The patient is motivated to practice on a daily basis, which shortens the time of recovery.

Traction and market

Every year it affects app. 5 million people worldwide. About ¼ of them is below 40 years old. Such number of patients has immense impact for health care systems and societies.  At this moment offered therapy is long, expensive an often ineffective.

Just in USA and EU from our product will benefit annually almost half a million patients who are in immediate need of the efficient therapy . On the global market it has potential to help millions people a year, and alleviate great expenditures of healthcare systems.

Based on scientific evidence, which shows that the brain stimulation, which is used in a device, can be estimated that increase in treatments success rate will rise around 50%. Thanks to the increased efficiency of treatment, the medical centres can serve up to 3 times more patients at the same time, resulting in large savings in medical staff. Moreover, the cheaper treatment and increased patient recovery rate directly reflect in decreased healthcare system expenses and amount of pensions to be paid to people who suffer from aphasia (in EU, the savings can reach even €3 billion every year).